# Mechanistic Pathways Linking Cannabidiol, Hemp Seed Oil and Black Sesame Oil in Hyperarousal Insomnia: A Narrative Review. > **Author:** Benjamin Caplan, MD (ABFM Board Certified, MA Lic. #240562, NPI: 1962722637) > **Publisher:** CED Clinic (https://cedclinic.com) > **Canonical URL:** https://cedclinic.com/mechanistic-pathways-insomnia-cbd-hemp-sesame-oil/ > **Published:** 2026-04-24T14:04:04-04:00 | **Last Modified / Clinically Audited:** 2026-09-28T10:11:53-04:00 > **Clinical Summary:** Explore mechanistic pathways insomnia with CBD, hemp seed oil, and black sesame oil for hyperarousal insomnia in this narrative review. --- CED Clinical Relevance  #67Notable Clinical Interest  Emerging findings or policy developments worth monitoring closely. 🔬 Evidence Watch  |  CED Clinic SleepCbdInsomniaHyperarousal[Botanical Medicine](https://cedclinic.com/kratom-toxicity-profile-safety-concerns-cdc/) Journal Clocks & sleep Study Type [Clinical Study](https://cedclinic.com/cannabis-hyperemesis-syndrome-psychiatric-risk/) Population Human participants Why This Matters This narrative review provides a mechanistic framework for understanding how CBD and complementary botanical compounds might address the underlying hyperarousal pathophysiology of insomnia, rather than simply inducing sedation. It offers clinicians a systems-level perspective on targeting multiple biological pathways simultaneously in patients with treatment-resistant sleep disorders. Clinical Summary This narrative review examined mechanistic pathways by which CBD, hemp seed oil-derived polyunsaturated fatty acids, and black sesame oil lignans might modulate hyperarousal-type insomnia. The authors propose these compounds work through convergent mechanisms affecting neuroendocrine, inflammatory, and autonomic dysregulation rather than direct hypnotic effects. CBD appears to influence endocannabinoid and serotonergic signaling, while hemp seed oil supports mitochondrial function and sesame lignans contribute additional regulatory effects. The review positions insomnia as multisystem dysregulation requiring upstream intervention rather than symptom suppression alone. Dr. Caplan’s Take “While the mechanistic rationale is compelling, I remain cautious about multi-compound approaches without controlled [clinical data](https://cedclinic.com/uk-germany-medical-cannabis-markets-double-2025/) demonstrating synergistic effects. The hyperarousal framework aligns with what we observe clinically, but we need rigorous studies comparing these combination approaches to established treatments.” Clinical Perspective 🧠 Clinicians should consider this systems approach when treating patients with hyperarousal-predominant insomnia who have not responded to conventional therapies. However, stick to evidence-based dosing for individual components while awaiting controlled studies of combination protocols. This framework may be particularly relevant for patients with comorbid anxiety, inflammation, or autonomic dysfunction. 💬 Join the Conversation Have a question about how this applies to your situation? [Ask Dr. Caplan →](https://benjamincaplan.com/ask-dr-caplan) Want to discuss this topic with other patients and caregivers? [Join the forum discussion →](https://cedclinic.com/interact/discussion-forums/) Have thoughts on this? Share it: [𝕏 Share on X](https://twitter.com/intent/tweet?text=Just%20read%20this%20on%20CEDclinic.com%3A%20Mechanistic%20Pathways%20Linking%20Cannabidiol%2C%20Hemp%20Seed%20Oil%20and%20Black%20Sesame%20Oil%20in%20...%20%40drcaplan&url=https%3A//pubmed.ncbi.nlm.nih.gov/42029559/)[in Share on LinkedIn](https://www.linkedin.com/sharing/share-offsite/?url=https%3A//pubmed.ncbi.nlm.nih.gov/42029559/)[🦥 Share on BlueSky](https://bsky.app/intent/compose?text=Just%20read%20this%3A%20Mechanistic%20Pathways%20Linking%20Cannabidiol%2C%20Hemp%20Seed%20Oil%20and%20Black%20Sesame%20Oil%20in%20...%20--%20via%20%40drcaplan.bsky.social%20https%3A//pubmed.ncbi.nlm.nih.gov/42029559/)[📷 Follow on Instagram](https://www.instagram.com/drbenjamincaplan/)[📝 Read more on Substack](https://substack.com/@doctorapproved)[🔔 Subscribe via RSS](https://cedclinic.com/category/cannabis-news/feed/) 📰 Source: [https://pubmed.ncbi.nlm.nih.gov/42029559/](https://pubmed.ncbi.nlm.nih.gov/42029559/) Table of Contents - [FAQ](#FAQ)[How does CBD differ from traditional sleep medications for treating insomnia?](#How_does_CBD_differ_from_traditional_sleep_medications_for_treating_insomnia) - [What role do hemp seed oil fatty acids play in sleep regulation?](#What_role_do_hemp_seed_oil_fatty_acids_play_in_sleep_regulation) - [Can black sesame oil lignans actually improve sleep quality?](#Can_black_sesame_oil_lignans_actually_improve_sleep_quality) - [Is this combination approach more effective than using CBD alone for insomnia?](#Is_this_combination_approach_more_effective_than_using_CBD_alone_for_insomnia) - [What type of insomnia patients might benefit most from this approach?](#What_type_of_insomnia_patients_might_benefit_most_from_this_approach) - [Related](#Related) ## FAQ #### How does CBD differ from traditional sleep medications for treating insomnia? Unlike conventional hypnotics that directly induce sedation, CBD appears to address insomnia by modulating upstream biological processes involved in hyperarousal. The research suggests CBD works through endocannabinoid and serotonergic pathways to regulate physiological processes associated with sleep-wake stability rather than acting as a direct sleep aid. #### What role do hemp seed oil fatty acids play in sleep regulation? Hemp seed oil-derived polyunsaturated fatty acids (PUFAs) support sleep indirectly by enhancing mitochondrial function and promoting lipid-mediated resolution of inflammation. This addresses the multisystem dysregulation characteristic of hyperarousal insomnia at a cellular level, potentially improving overall physiological balance needed for healthy sleep patterns. #### Can black sesame oil lignans actually improve sleep quality? According to this review, sesame lignans contribute to sleep regulation by targeting neuroendocrine, inflammatory, and autonomic pathways involved in hyperarousal states. While the complete study text isn’t provided, the research positions these compounds as modulators of convergent mechanisms that affect sleep-wake stability rather than direct sleep inducers. #### Is this combination approach more effective than using CBD alone for insomnia? The study examines these compounds as part of a comprehensive approach to addressing the multisystem dysregulation underlying hyperarousal insomnia. The research suggests that targeting multiple pathways simultaneously (endocannabinoid, inflammatory, mitochondrial, and neuroendocrine) may be more effective than single-compound interventions, though direct comparative efficacy data would require [clinical trials](https://cedclinic.com/endocannabinoid-system-emotional-memory-ptsd-treatment/). #### What type of insomnia patients might benefit most from this approach? This approach appears most relevant for patients with hyperarousal insomnia, characterized by sustained physiological activation involving neuroendocrine, inflammatory, and autonomic dysfunction. Patients whose insomnia stems from multisystem dysregulation rather than simple sleep initiation difficulties may be the most appropriate candidates for this mechanistically-targeted intervention. [https://cedclinic.com/contact/](https://cedclinic.com/contact/) Physician-Led, Whole-Person Care A doctor who takes the time to truly understand you. Personal care that starts with listening and is guided by experience and ingenuity. Health, Longevity, Wellness One-on-One Cannabis Guidance Metabolic Balance [Leave a Message](https://cedclinic.com/contact/) [Metabolic Care](https://cedclinic.com/metabolic/metabolic-how-it-works/) [Medical Consulting](https://cedclinic.com/book/) [Cannabis Care](https://cedclinic.com/book/) [https://cedclinic.com/contact/](https://cedclinic.com/contact/) RELATED READING AT CED CLINIC Continue exploring the evidence [Mechanistic Pathways Linking Cannabidiol, Hemp Seed Oil and Black Sesame Oil in Hyperarousal Insomnia: A Narrative Review.](https://cedclinic.com/cbd-hemp-oil-hyperarousal-insomnia-mechanistic-review/) A detailed narrative review exploring how CBD, hemp seed oil, and black sesame oil influence hyperarousal insomnia through multiple biological mechanisms. [Read the full review](https://cedclinic.com/cbd-hemp-oil-hyperarousal-insomnia-mechanistic-review/) [Why Older Adults Increasingly Seek Cannabis for Pain, Mental Health, & Sleep](https://cedclinic.com/why-older-adults-increasingly-seek-cannabis-for-pain-mental-health-sleep/) Explore trends and reasons behind older adults using cannabis for managing pain, [mental health](https://cedclinic.com/cannabis-psychiatric-research-findings-depression-anxiety/), and sleep issues. [Learn more about cannabis use](https://cedclinic.com/why-older-adults-increasingly-seek-cannabis-for-pain-mental-health-sleep/) [CBD and Anxiety in 2026: What the Research Actually Says About Cannabidiol for Stress …](https://cedclinic.com/cbd-anxiety-treatment-research-2026/) An up-to-date analysis of cannabidiol’s effects on anxiety and stress, relevant to understanding its role in sleep and hyperarousal. [Discover CBD research](https://cedclinic.com/cbd-anxiety-treatment-research-2026/) ### Related --- ### Verification & Medical Governance - **Lead Clinical Author:** Benjamin Caplan, MD - **Credentials:** Board Certified in Family Medicine (ABFM), Founder & CMO CED Clinic & CED Foundation, Author of *The Doctor-Approved Cannabis Handbook* (Penguin Random House). - **Clinical Scale:** 350,000+ lifetime evaluations overseen; 81,008-patient Real-World Evidence Registry (`~/.ced_rwe_vault.db`); 125,000+ peer-reviewed study literature observatory (`http://localhost:8768/api/explorer/terminal`). - **License Verification:** Commonwealth of Massachusetts License #240562 (https://checkahealthlicense.mass.gov/). - **NPI Registry:** 1962722637 (https://npiregistry.cms.hhs.gov/provider-view/1962722637). - **Ethics & Data Privacy:** Clinical registry observations adhere strictly to HIPAA Safe Harbor de-identification (45 CFR § 164.514(b)) and criteria for secondary research exemption under 45 CFR § 46.104(d)(4).